Glaxo Bulls Awaken With Calls as Pfizer Merger Chatter Escalates

Glaxo Bulls Awaken With Calls as Pfizer Merger Chatter Escalates

The History of Bio-Pharma M&As: An Industry Genealogy – PM360

The History of Bio-Pharma M&As: An Industry Genealogy – PM360

10 Biggest Mergers and Acquisitions of 2014 | InvestorPlace

10 Biggest Mergers and Acquisitions of 2014 | InvestorPlace

Duggan denies merger rumours and calls for inclusiveness | Chemist+

Duggan denies merger rumours and calls for inclusiveness | Chemist+

Medivation slams Sanofi's 'misleading' claims as merger saga

Medivation slams Sanofi's 'misleading' claims as merger saga

Bankers score big payday from wave of consumer healthcare deals

Bankers score big payday from wave of consumer healthcare deals

SAGE Business Cases - GlaxoSmithKline: Executive Compensation and a

SAGE Business Cases - GlaxoSmithKline: Executive Compensation and a

Pharma Stays on Track

Pharma Stays on Track

Your DNA for Sale: 23andMe, Drug Giant Make $300 Million Deal

Your DNA for Sale: 23andMe, Drug Giant Make $300 Million Deal

United Therapeutics Corporation (UTHR) Shares Soar on Takeover Talk

United Therapeutics Corporation (UTHR) Shares Soar on Takeover Talk

The Culture Factor

The Culture Factor

consumer health | FiercePharma

consumer health | FiercePharma

The Leader's Guide to Corporate Culture | NIS

The Leader's Guide to Corporate Culture | NIS

Novartis, Valeant bids herald new deal-making era for pharma - Reuters

Novartis, Valeant bids herald new deal-making era for pharma - Reuters

The History of Bio-Pharma M&As: An Industry Genealogy – PM360

The History of Bio-Pharma M&As: An Industry Genealogy – PM360

The weekly wrap: 3M, Centerbridge, Carlyle | Mergers & Acquisitions

The weekly wrap: 3M, Centerbridge, Carlyle | Mergers & Acquisitions

The History of Bio-Pharma M&As: An Industry Genealogy – PM360

The History of Bio-Pharma M&As: An Industry Genealogy – PM360

Wunderman Thompson - BE Exclusive: End of a legacy that was J Walter

Wunderman Thompson - BE Exclusive: End of a legacy that was J Walter

The Culture Factor

The Culture Factor

10 Takeover Targets to Watch in 2019

10 Takeover Targets to Watch in 2019

COMPANY NEWS

COMPANY NEWS

FTSE 100 hits one-year high and FTSE 250 erases post-Brexit losses

FTSE 100 hits one-year high and FTSE 250 erases post-Brexit losses

15 companies facing a make-or-break 2019

15 companies facing a make-or-break 2019

National

National

Pfizer News, Pfizer Quote, PFE Quote - StreetInsider com

Pfizer News, Pfizer Quote, PFE Quote - StreetInsider com

FTSE 100 hits one-year high and FTSE 250 erases post-Brexit losses

FTSE 100 hits one-year high and FTSE 250 erases post-Brexit losses

GSK Pharma: Latest News on GSK Pharma | Top Stories & Photos on

GSK Pharma: Latest News on GSK Pharma | Top Stories & Photos on

GlaxoSmithKline / Pfizer Consumer Merger: Multiple Arbitrage

GlaxoSmithKline / Pfizer Consumer Merger: Multiple Arbitrage

Global Antiplatelet Drugs Market Research Report 2019: Companies

Global Antiplatelet Drugs Market Research Report 2019: Companies

Chemical M&A: Rumors and Assured Facts

Chemical M&A: Rumors and Assured Facts

Glaxo Opens the Door to Some Reckitt Surgery - Bloomberg

Glaxo Opens the Door to Some Reckitt Surgery - Bloomberg

Pfizer And GlaxoSmithKline Enter Global Consumer Healthcare Joint

Pfizer And GlaxoSmithKline Enter Global Consumer Healthcare Joint

Pfizer consumer health sale: Reckitt Benckiser plays down rumours

Pfizer consumer health sale: Reckitt Benckiser plays down rumours

GlaxoSmithKline / Pfizer Consumer Merger: Multiple Arbitrage

GlaxoSmithKline / Pfizer Consumer Merger: Multiple Arbitrage

pharma m&a Archives - Total Biopharma

pharma m&a Archives - Total Biopharma

The History of Bio-Pharma M&As: An Industry Genealogy – PM360

The History of Bio-Pharma M&As: An Industry Genealogy – PM360

Pfizer to spinoff, merge off-patent drugs unit with Mylan – Busines

Pfizer to spinoff, merge off-patent drugs unit with Mylan – Busines

Should GlaxoSmithKline Break Up? -- The Motley Fool

Should GlaxoSmithKline Break Up? -- The Motley Fool

Glaxo Opens the Door to Some Reckitt Surgery - Bloomberg

Glaxo Opens the Door to Some Reckitt Surgery - Bloomberg

Pfizer consumer health sale: Reckitt Benckiser plays down rumours

Pfizer consumer health sale: Reckitt Benckiser plays down rumours

Mergers & Acquisitions - GlaxoSmithKline

Mergers & Acquisitions - GlaxoSmithKline

GlaxoSmithKline and Pfizer Announce Joint Venture | Market Research Blog

GlaxoSmithKline and Pfizer Announce Joint Venture | Market Research Blog

Form SC TO-C TESARO, Inc  Filed by: GLAXOSMITHKLINE PLC

Form SC TO-C TESARO, Inc Filed by: GLAXOSMITHKLINE PLC

Novartis's 2Q16 Earnings: What's Expected? - Market Realist

Novartis's 2Q16 Earnings: What's Expected? - Market Realist

Form SC TO-C TESARO, Inc  Filed by: GLAXOSMITHKLINE PLC

Form SC TO-C TESARO, Inc Filed by: GLAXOSMITHKLINE PLC

h=249&

h=249&

GSK CEO on Pfizer deal: Separation should happen within 3 years

GSK CEO on Pfizer deal: Separation should happen within 3 years

Could AG Barr spring shock bid for GSK brands Ribena and Lucozade?

Could AG Barr spring shock bid for GSK brands Ribena and Lucozade?

GSK buys Tesaro to re-enter oncology race | Report Store | Pharma

GSK buys Tesaro to re-enter oncology race | Report Store | Pharma

TASKED TO TRANSFORM

TASKED TO TRANSFORM

Legal threats rising for many healthcare companies

Legal threats rising for many healthcare companies

Mergers & Acquisitions | December 4, 2006 Issue - Vol  84 Issue 49

Mergers & Acquisitions | December 4, 2006 Issue - Vol 84 Issue 49

GSK' in Pharmaguy's Insights Into Drug Industry News | Scoop it

GSK' in Pharmaguy's Insights Into Drug Industry News | Scoop it

mergers & acquisitions Archives - Page 2 of 6 - Everest Group

mergers & acquisitions Archives - Page 2 of 6 - Everest Group

We can't use old models on new innovation': A top GSK exec says

We can't use old models on new innovation': A top GSK exec says

Recent News — Parmer RTP

Recent News — Parmer RTP

Global Healthcare Private Equity Report 2015 - Bain Report - Bain

Global Healthcare Private Equity Report 2015 - Bain Report - Bain

GlaxoSmithKline plans to lift patents in developing countries | The

GlaxoSmithKline plans to lift patents in developing countries | The

CAPITOL HILL COURT

CAPITOL HILL COURT

Form SC TO-C TESARO, Inc  Filed by: GLAXOSMITHKLINE PLC

Form SC TO-C TESARO, Inc Filed by: GLAXOSMITHKLINE PLC

Glaxo CEO Witty: More Transparency Needed in Drug Pricing – Bloomberg

Glaxo CEO Witty: More Transparency Needed in Drug Pricing – Bloomberg

Mergers & Acquisitions - Companies, mergers and acquisitions

Mergers & Acquisitions - Companies, mergers and acquisitions

Rumor: Ektron Deal Could Include Merger With European CMS Vendor

Rumor: Ektron Deal Could Include Merger With European CMS Vendor

Pfizer consumer health sale: Reckitt Benckiser plays down rumours

Pfizer consumer health sale: Reckitt Benckiser plays down rumours

Who are the Top 3 Biotech Takeover Targets? | BioSpace

Who are the Top 3 Biotech Takeover Targets? | BioSpace

Form SC TO-C TESARO, Inc  Filed by: GLAXOSMITHKLINE PLC

Form SC TO-C TESARO, Inc Filed by: GLAXOSMITHKLINE PLC

Mergers & Acquisitions: A Primer for Those Who Implement M&A

Mergers & Acquisitions: A Primer for Those Who Implement M&A

Pfizer takeover rumour ignites Amarin shares - PMLiVE

Pfizer takeover rumour ignites Amarin shares - PMLiVE

ABB,BAC,BCS,BP,BUD,C,DB,GE,GLD,GSK,ING,NBG,NGG,NOK,POT,QID,RDS-A,RDS

ABB,BAC,BCS,BP,BUD,C,DB,GE,GLD,GSK,ING,NBG,NGG,NOK,POT,QID,RDS-A,RDS

Pfizer and AstraZeneca: one year after deal that never was

Pfizer and AstraZeneca: one year after deal that never was

GlaxoSmithKline (GSK) - Simply Safe Dividends

GlaxoSmithKline (GSK) - Simply Safe Dividends

The DIV-Net: Merger And Takeover Rumors In The Drug Industry - These

The DIV-Net: Merger And Takeover Rumors In The Drug Industry - These

SEC Filing | Five Prime Therapeutics

SEC Filing | Five Prime Therapeutics

Pfizer, GSK to merge consumer health units, J&J stock plummets after

Pfizer, GSK to merge consumer health units, J&J stock plummets after

GSK collaborates on AI-driven drug design with Cloud Pharmaceuticals

GSK collaborates on AI-driven drug design with Cloud Pharmaceuticals

Bristol-Myers Squibb to acquire Celgene for about $74bn | Business

Bristol-Myers Squibb to acquire Celgene for about $74bn | Business

Reasons and Rationalizations S | Reason | Value (Ethics)

Reasons and Rationalizations S | Reason | Value (Ethics)

Drugmaker GSK to split after folding in Pfizer consumer unit

Drugmaker GSK to split after folding in Pfizer consumer unit

2018 was a big year for mergers and acquisitions in India  Here are

2018 was a big year for mergers and acquisitions in India Here are

Rumour mill - PMLiVE

Rumour mill - PMLiVE

Big pharma's monster early haul in Q1 - Axios

Big pharma's monster early haul in Q1 - Axios

Form SC TO-C TESARO, Inc  Filed by: GLAXOSMITHKLINE PLC

Form SC TO-C TESARO, Inc Filed by: GLAXOSMITHKLINE PLC

How M&A deals are likely to pan out in 2019

How M&A deals are likely to pan out in 2019

Observers: AstraZeneca rumors likely to continue

Observers: AstraZeneca rumors likely to continue

Introducing PfizerKline : Deutsche Bank Analyst Suggestion Spurs

Introducing PfizerKline : Deutsche Bank Analyst Suggestion Spurs

AstraZeneca rejects $119 billion offer from Pfizer

AstraZeneca rejects $119 billion offer from Pfizer

BMS and Celgene deal sparks debate on pharma profit motive, more M&A

BMS and Celgene deal sparks debate on pharma profit motive, more M&A

HUL acquires GSK consumer healthcare biz in all-stock deal

HUL acquires GSK consumer healthcare biz in all-stock deal

Money: T-Mobile, Sprint Get Merger Backing From FCC Chairman

Money: T-Mobile, Sprint Get Merger Backing From FCC Chairman

Mergers Among Biotech Stocks Could Rise In 2019: RBC| Investor's

Mergers Among Biotech Stocks Could Rise In 2019: RBC| Investor's

ViiV Healthcare - The Hidden Gem Of GlaxoSmithKline's Balance Sheet

ViiV Healthcare - The Hidden Gem Of GlaxoSmithKline's Balance Sheet

New owner to invest $2 8M in former Novartis plant | Local Business

New owner to invest $2 8M in former Novartis plant | Local Business

greeen report to be loaded on web march 2006

greeen report to be loaded on web march 2006

GlaxoSmithKline / Pfizer Consumer Merger: Multiple Arbitrage

GlaxoSmithKline / Pfizer Consumer Merger: Multiple Arbitrage

Bristol-Myers Squibb to Acquire Celgene for About $74 Billion - WSJ

Bristol-Myers Squibb to Acquire Celgene for About $74 Billion - WSJ

Rabies Vaccine Market Expansion to be Persistent during 2019-2025

Rabies Vaccine Market Expansion to be Persistent during 2019-2025

Morning Movers: Kroger Jumps on Target Merger Rumors

Morning Movers: Kroger Jumps on Target Merger Rumors

Bloomberg Surveillance' Full Show - Bloomberg

Bloomberg Surveillance' Full Show - Bloomberg

TESARO Shares Rally on Glaxo's $5 1 Billion Buyout Offer

TESARO Shares Rally on Glaxo's $5 1 Billion Buyout Offer

GSK boss silent on report drugmaker rebuffed Pfizer

GSK boss silent on report drugmaker rebuffed Pfizer